郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Female Syrian hamster analyses of bremelanotide, a US FDA approved drug for the treatment of female hypoactive sexual desire disorder.

期刊：Neuropharmacology发表年份：2025作者：Johnathan M Borland; Abigail L Kohut-Jackson; Anna C Peyla; Megan Al Hall; Paul G Mermelstein; Robert L Meisel
阅读更多 →

药效评价Discovery of potent and orally bioavailable benzothiazole-benzenesulfonamide derivatives as ABCA1 upregulators for the management of dyslipidemia.

期刊：European journal of medicinal chemistry发表年份：2026作者：Wenyan Li; Lijuan Lei; Guosheng Zhang; Yunjin Zhang; Yujie Wang; Yexiang Wu; Ren Sheng; Guijun Yang; Yanni Xu; Hongtao Liu
阅读更多 →

药效评价Hexarelin promotes the survival of retinal ganglion cells after optic nerve transection.

期刊：Indian journal of pharmacology发表年份：2026作者：Kevin Bing Shui Chow
阅读更多 →

药效评价Topical microemulsion with phenolic compounds from Libidibia ferrea (Fabaceae): An alternative treatment for cutaneous leishmaniasis.

期刊：European journal of microbiology & immunology发表年份：2025作者：Bruno Bezerra Jensen; Katia Solange Cardoso Rodrigues Dos Santos; Claudia Dantas Comandolli-Wyrepkowski; Felipe Moura Araujo da Silva; Caio Coutinho de Souza; Maria da Paz Lima; José Fernando Marques Barcellos; Tatiane Pereira de Souza; Fabrício Nona
阅读更多 →